Source: Advanced Proteome Therapeutics Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Advanced Proteome Therapeutics  (APC) has closed a non-brokered private placement raising gross proceeds of $72,500.00
  • The company issued 1,450,000 shares at a price of $0.05 per share
  • The gross proceeds of the offering will be used for general working capital
  • Advanced Proteome Therapeutics Corp is a biotechnology company
  • Advanced Proteome Therapeutics Corp. (APC) opened trading at C$0.045

Advanced Proteome Therapeutics  (APC) has closed a non-brokered private placement raising gross proceeds of $72,500.00.

The company issued 1,450,000 shares at a price of $0.05 per share.

There were no finders’ fees paid in connection with the offering.

All securities issued will be subject to a statutory four-month hold period expiring on April 24, 2023.

The gross proceeds of the offering will be used for general working capital.

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., is developing a proprietary technology to directly target cancerous tumours and avoid destroying normal cells. This type of agent is capable of greater potency, higher specificity, and lower toxicity than other therapies that can also attack healthy cells. Advanced Proteome is working to streamline the process by which these agents are prepared, which to date, has been extremely cumbersome, limiting their potential.

Advanced Proteome Therapeutics Corp. (APC) opened trading at C$0.045.


More From The Market Herald

" @ the Bell: Tech leads TSX comeback

It was another rocky day for Canada’s main stock index that ultimately ended up in the green thanks to a lead powered by
Geomega Resources - President & CEO, Kiril Mugerman

" Geomega Resources (TSXV:GMA) granted $3M for recycling demo plant

Geomega Resources (GMA) has been awarded a $3 million grant from the government of Quebec’s Technoclimat Program.
First Hydrogen Corp. - CEO of Automotive, Steve Gill.

" First Hydrogen (TSXV:FHYD) unveils next gen FCEV images

First Hydrogen (FHYD) has received the initial Generation II images for its hydrogen fuel cell vehicle (FCEV), designed in collaboration with EDAG Group.
The Tugaske Project.

" Gensource Potash (TSXV:GSP) closes non-brokered private placement

Gensource Potash Corporation (GSP) has closed its previously announced non-brokered private placement of units and flow-through common shares.